1,788
Views
1
CrossRef citations to date
0
Altmetric
Pregnancy, Childbirth & Women’s Health

Prevalence, risk factors and adverse perinatal outcomes for Chinese women with intrahepatic cholestasis of pregnancy: a large cross-sectional retrospective study

, , , & ORCID Icon
Pages 2965-2973 | Received 09 Feb 2022, Accepted 08 Oct 2022, Published online: 22 Oct 2022

References

  • Allen AM, Kim WR, Larson JJ, et al. The epidemiology of liver diseases unique to pregnancy in a US community: a population-based study. Clin Gastroenterol Hepatol. 2016;14(2):287–294. e281–282.
  • Joshi D, James A, Quaglia A, et al. Liver disease in pregnancy. Lancet. 2010;375(9714):594–605.
  • Di Mascio D, Quist-Nelson J, Riegel M, et al. Perinatal death by bile acid levels in intrahepatic cholestasis of pregnancy: a systematic review. J Matern Fetal Neonatal Med. 2021;34(21):3614–3622.
  • Roediger R, Fleckenstein J. Intrahepatic cholestasis of pregnancy: natural history and current management. Semin Liver Dis. 2021;41(1):103–108.
  • Williamson C, Geenes V. Intrahepatic cholestasis of pregnancy. Obstet Gynecol. 2014;124(1):120–133.
  • Floreani A, Gervasi MT. New insights on intrahepatic cholestasis of pregnancy. Clin Liver Dis. 2016;20(1):177–189.
  • Mor M, Shmueli A, Krispin E, et al. Intrahepatic cholestasis of pregnancy as a risk factor for preeclampsia. Arch Gynecol Obstet. 2020;301(3):655–664.
  • Marschall HU, Wikström Shemer E, Ludvigsson JF, et al. Intrahepatic cholestasis of pregnancy and associated hepatobiliary disease: a population-based cohort study. Hepatology. 2013;58(4):1385–1391.
  • Liu C, Gao J, Liu J, et al. Intrahepatic cholestasis of pregnancy is associated with an increased risk of gestational diabetes and preeclampsia. Ann Transl Med. 2020;8(23):1574.
  • Kawakita T, Parikh LI, Ramsey PS, et al. Predictors of adverse neonatal outcomes in intrahepatic cholestasis of pregnancy. Am J Obstet Gynecol. 2015;213(4):570–578.
  • Ovadia C, Seed PT, Sklavounos A, et al. Association of adverse perinatal outcomes of intrahepatic cholestasis of pregnancy with biochemical markers: results of aggregate and individual patient data meta-analyses. Lancet. 2019;393(10174):899–909.
  • Zecca E, De Luca D, Marras M, et al. Intrahepatic cholestasis of pregnancy and neonatal respiratory distress syndrome. Pediatrics. 2006;117(5):1669–1672.
  • Herrera CA, Manuck TA, Stoddard GJ, et al. Perinatal outcomes associated with intrahepatic cholestasis of pregnancy. J Matern Fetal Neonatal Med. 2018;31(14):1913–1920.
  • Jurk SM, Kremer AE, Schleussner E. Intrahepatic cholestasis of pregnancy. Geburtshilfe Frauenheilkd. 2021;81(8):940–947.
  • Dixon PH, Wadsworth CA, Chambers J, et al. A comprehensive analysis of common genetic variation around six candidate loci for intrahepatic cholestasis of pregnancy. Am J Gastroenterol. 2014;109(1):76–84.
  • Smith DD, Rood KM. Intrahepatic cholestasis of pregnancy. Clin Obstet Gynecol. 2020;63(1):134–151.
  • Rezai S, Lora I, Henderson CE. Severe intrahepatic cholestasis of pregnancy is a risk factor for preeclampsia in singleton and twin pregnancies. Am J Obstet Gynecol. 2015;213(6):877.
  • Bolukbas FF, Bolukbas C, Balaban HY, et al. Intrahepatic cholestasis of pregnancy: spontaneous vs in vitro fertilization. Euroasian J Hepatogastroenterol. 2017;7(2):126–129.
  • Bicocca MJ, Sperling JD, Chauhan SP. Intrahepatic cholestasis of pregnancy: review of six national and regional guidelines. Eur J Obstet Gynecol Reprod Biol. 2018;231:180–187.
  • Wijarnpreecha K, Thongprayoon C, Sanguankeo A, et al. Hepatitis C infection and intrahepatic cholestasis of pregnancy: a systematic review and meta-analysis. Clin Res Hepatol Gastroenterol. 2017;41(1):39–45.
  • Glantz A, Marschall HU, Mattsson LA. Intrahepatic cholestasis of pregnancy: relationships between bile acid levels and fetal complication rates. Hepatology. 2004;40(2):467–474.
  • Gao XX, Ye MY, Liu Y, et al. Prevalence and risk factors of intrahepatic cholestasis of pregnancy in a chinese population. Sci Rep. 2020;10(1):16307.
  • Jing He HX, Duan T, Liu X, et al. Guidelines for the management of intrahepatic cholestasis of pregnancy (2015). J Clin Hepatol. 2015;31(10):4.
  • Guidelines IOMU. Weight gain during pregnancy: reexamining the guidelines, national academy of sciences. Washington (DC): National Academies Press (US); 2009.
  • Luo XL, Zhang WY. Obstetrical disease spectrum in China: an epidemiological study of 111,767 cases in 2011. Chin Med J. 2015;128(9):1137–1146.
  • Gonzalez MC, Reyes H, Arrese M, et al. Intrahepatic cholestasis of pregnancy in twin pregnancies. J Hepatol. 1989;9(1):84–90.
  • Koivurova S, Hartikainen AL, Karinen L, et al. The course of pregnancy and delivery and the use of maternal healthcare services after standard IVF in Northern Finland 1990-1995. Hum Reprod. 2002;17(11):2897–2903.
  • Heinonen S, Kirkinen P. Pregnancy outcome with intrahepatic cholestasis. Obstet Gynecol. 1999;94(2):189–193.
  • Kremer AE, Wolf K, Ständer S. Intrahepatic cholestasis of pregnancy: rare but important. Hautarzt. 2017;68(2):95–102.
  • Locatelli A, Roncaglia N, Arreghini A, et al. Hepatitis C virus infection is associated with a higher incidence of cholestasis of pregnancy. Br J Obstet Gynaecol. 1999;106(5):498–500.
  • Paternoster DM, Fabris F, Palù G, et al. Intra-hepatic cholestasis of pregnancy in hepatitis C virus infection. Acta Obstet Gynecol Scand. 2002;81(2):99–103.
  • Geenes V, Williamson C. Intrahepatic cholestasis of pregnancy. World J Gastroenterol. 2009;15(17):2049–2066.
  • Wu K, Wang H, Li S, et al. Maternal hepatitis B infection status and adverse pregnancy outcomes: a retrospective cohort analysis. Arch Gynecol Obstet. 2020;302(3):595–602.
  • Tan J, Liu X, Mao X, et al. HBsAg positivity during pregnancy and adverse maternal outcomes: a retrospective cohort analysis. J Viral Hepat. 2016;23(10):812–819.
  • Cai Q, Liu H, Han W, et al. Maternal HBsAg carriers and adverse pregnancy outcomes: a hospital-based prospective cohort analysis. J Viral Hepat. 2019;26(8):1011–1018.
  • Tse KY, Ho LF, Lao T. The impact of maternal HBsAg carrier status on pregnancy outcomes: a case-control study. J Hepatol. 2005;43(5):771–775.
  • Medina Lomelí JM, Jáuregui Meléndrez RA, Medina Castro N, et al. Intrahepatic cholestasis of pregnancy: review. Ginecol Obstet Mex. 2012;80(4):285–294.
  • Larson SP, Kovilam O, Agrawal DK. Immunological basis in the pathogenesis of intrahepatic cholestasis of pregnancy. Expert Rev Clin Immunol. 2016;12(1):39–48.
  • Savander M, Ropponen A, Avela K, et al. Genetic evidence of heterogeneity in intrahepatic cholestasis of pregnancy. Gut. 2003;52(7):1025–1029.
  • Abu-Hayyeh S, Ovadia C, Lieu T, et al. Prognostic and mechanistic potential of progesterone sulfates in intrahepatic cholestasis of pregnancy and pruritus gravidarum. Hepatology. 2016;63(4):1287–1298.
  • Crocenzi FA, Mottino AD, Cao J, et al. Estradiol-17beta-D-glucuronide induces endocytic internalization of bsep in rats. Am J Physiol Gastrointest Liver Physiol. 2003;285(2):G449–G459.
  • Chappell LC, Bell JL, Smith A, et al. Ursodeoxycholic acid versus placebo in women with intrahepatic cholestasis of pregnancy (PITCHES): a randomised controlled trial. Lancet. 2019;394(10201):849–860.
  • Kondrackiene J, Beuers U, Zalinkevicius R, et al. Predictors of premature delivery in patients with intrahepatic cholestasis of pregnancy. World J Gastroenterol. 2007;13(46):6226–6230.
  • Shaw D, Frohlich J, Wittmann BA, et al. A prospective study of 18 patients with cholestasis of pregnancy. Am J Obstet Gynecol. 1982;142(6):621–625.
  • Kenyon AP, Piercy CN, Girling J, et al. Obstetric cholestasis, outcome with active management: a series of 70 cases. BJOG. 2002;109(3):282–288.
  • EASL. Clinical practice guidelines: management of cholestatic liver diseases. J Hepatol. 2009;51(2):237–267.